SAM #6052521200172

Award for Emergency Procurement of Breyanzi CAR-T Therapy from Bristol-Myers Squibb

This award notice details the Department of Veterans Affairs' urgent procurement of Breyanzi, a specialized CAR-T-cell therapy, for the VA Phoenix Healthcare System Pharmacy Service. - Government Buyer: - Department of Veterans Affairs - Network Contracting Office 22 - VA Phoenix Healthcare System Pharmacy Service - OEM Highlight: - Bristol-Myers Squibb Company is the sole manufacturer and supplier of Breyanzi - Product/Service Details: - Product: Breyanzi (autologous CAR-T-cell therapy) - Quantity: 1 treatment - Description: FDA-approved, patient-specific therapy for relapsed or refractory B-cell lymphomas - Part number: Not specified - Procured under FSS Contract 36F79724D0101 - Notable Requirements: - Urgent, sole-source procurement due to patient treatment schedule - Only available directly from Bristol-Myers Squibb Company - McKesson Specialty acts as distributor, but OEM is Bristol-Myers Squibb - Estimated contract value: $364,139.25 - No competing products or alternative therapies specified due to the unique, proprietary nature of Breyanzi

View original listing